Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alimera Sciences, Inc. - Common Stock (NQ:ALIM)

5.540 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Alimera Sciences, Inc. - Common Stock

< Previous 1 2 Next >
Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook
Via Benzinga
Exposures Fossil Fuels
Dow Dips Around 1%; US Small Business Optimism Falls In August
Via Benzinga
Topics Stocks
Exposures US Equities
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q2 2024
ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps 300 Points; Alimera Sciences Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
A Preview Of Alimera Sciences's Earnings
Via Benzinga
The Latest Analyst Ratings for Alimera Sciences
Via Benzinga
Preview: Alimera Sciences's Earnings
Via Benzinga
Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To Know
Via Benzinga
Why Is MicroAlgo (MLGO) Stock Up 113% Today?
MicroAlgo stock is up on Monday after the company revealed in an SEC filing that an investor now holds an almost 14% stake in MLGO. 
Via InvestorPlace
Topics Regulatory Compliance
Exposures Legal Regulatory
Why Is Alimera Sciences (ALIM) Stock Up 77% Today?
Alimera Sciences stock is up on Monday as investors react to a $5.50 per share acquisition offer for ALIM from ANI Pharmaceuticals. 
Via InvestorPlace
Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal
ANI Pharmaceuticals to acquire Alimera Sciences for $5.50 per share in cash, plus a contingent value right of up to $0.50 per share. The transaction is valued at $381 million and is expected to close... 
Via Benzinga
ALIM Stock Earnings: Alimera Sciences Misses EPS, Beats Revenue for Q1 2024
ALIM stock results show that Alimera Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
ALIM Stock Earnings: Alimera Sciences Beats Revenue for Q4 2023
ALIM stock results show that Alimera Sciences beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Expert Ratings for Alimera Sciences
Via Benzinga
4 Analysts Have This to Say About Alimera Sciences
Via Benzinga
Earnings Outlook For Alimera Sciences
Via Benzinga
Earnings Scheduled For March 7, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023
Via Benzinga
10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & More
Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for the next huge move. High short interest and steep borrowing costs are among... 
Via Benzinga
Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket
Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off the final day of the trading week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers CaliberCos Inc. (NASDAQ: CWD) shares jumped 65.6% to $9.94 amid post-IPO volatility. 
Via Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT). 
Via InvestorPlace
US Stocks Mixed; Jobless Claims Drop More than Projected
U.S. stocks traded mixed this morning, with the Dow Jones dropping around 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.31% to 33,315.53 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus Royalties
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has agreed to sell Yutiq (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences Inc (NASDAQ: ALIM).  
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.